Medicare Enrolled
Dr. Vijay Bahl, MD
Endocrinology · Pittsburgh, PA
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Speaking/Promotional
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Bahl from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Bahl?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Bahl
Dr. Vijay Bahl is an endocrinology specialist in Pittsburgh, PA, with 19 years of NPI registration. Based on federal Medicare data, Dr. Bahl performed 2,328 Medicare services across 970 unique beneficiaries.
Between the years covered by Open Payments, Dr. Bahl received a total of $1,122,929 from 68 pharmaceutical and/or device companies across 3225 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in endocrinology. The majority of payments are for speaking programs and promotional activities, reflecting participation in industry-sponsored events. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Bahl is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 19 years in practice
▲ Top 16% volume in PA
$1,122,929 industry payments
Medicare Practice Summary
Medicare Utilization ↗2,328
Medicare services
Top 16% in PA for endocrinology
970
Unique beneficiaries
$56
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~123 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Hospital follow-up visit, moderate complexity Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service. |
708 | $61 | $135 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
656 | $58 | $120 |
| Hospital follow-up visit, low complexity Follow-up hospital visit for an established patient with straightforward or low-level medical decision making. The visit requires at least 25 minutes of time spent on the day of service. |
466 | $38 | $125 |
| Initial hospital admission, high complexity Initial hospital inpatient or observation care for a new patient involving high-level medical decision making, with at least 75 minutes total time on the date of the encounter. |
140 | $133 | $275 |
| Blood draw (venipuncture) Insertion of a needle into a vein to collect a blood sample. |
98 | $8 | $10 |
| Hemoglobin A1c test (diabetes monitoring) A blood test that measures your average blood sugar levels over the past two to three months. |
96 | $9 | $30 |
| New patient office visit (30-44 min) An initial office visit for a new patient lasting between 30 and 44 minutes. This code is used when the total time spent on the date of the encounter falls within this range. |
35 | $80 | $175 |
| Initial hospital admission, moderate complexity Initial hospital inpatient or observation care for a new patient involving moderate-level medical decision making, with at least 55 minutes total time on the date of the encounter. |
27 | $100 | $225 |
| Continuous glucose monitoring with interpretation This procedure involves monitoring blood sugar levels in tissue fluid using a sensor placed under the skin, along with the interpretation and reporting of the results. |
25 | $26 | $50 |
| Hospital discharge day management, 30 minutes or less This service covers the final day of hospital care when the patient is being discharged. It includes coordination of care and instructions for the patient within a time frame of 30 minutes or less. |
21 | $62 | $150 |
| Hospital follow-up visit, high complexity Subsequent hospital inpatient or observation care for an existing patient involving high-level medical decision making, with at least 50 minutes total time on the date of the encounter. |
20 | $91 | $165 |
| Quadrivalent influenza vaccine, cell-culture derived A flu shot containing four strains of influenza virus, produced using cell culture technology rather than eggs. This formulation is free from preservatives and antibiotics. |
19 | $33 | $40 |
| Flu vaccine administration This procedure involves the administration of the influenza virus vaccine. It covers the process of delivering the vaccine to the patient. |
17 | $29 | $35 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
Industry Payment Transparency
Open Payments through 2024 ↗$1,122,929
Total received (2018-2024)
Avg $160,418/year across 7 years
Top 0% in PA for endocrinology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
68
Companies
3,225
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$1,109,432 (98.8%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$13,497 (1.2%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$122,366
2023
$80,250
2022
$141,599
2021
$120,012
2020
$140,938
2019
$267,279
2018
$250,485
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
Lilly USA, LLC
$64,743
Bayer Healthcare Pharmaceuticals Inc.
$38,079
Amgen Inc.
$8,731
Novo Nordisk Inc
$5,970
Boehringer Ingelheim Pharmaceuticals, Inc.
$2,180
Dexcom, Inc.
$748
AstraZeneca Pharmaceuticals LP
$302
Amneal Pharmaceuticals LLC
$281
ABBVIE INC.
$226
Abbott Laboratories
$194
CeQur Corporation
$149
Medtronic, Inc.
$90
Corcept Therapeutics
$87
Astellas Pharma US Inc
$85
PFIZER INC.
$65
Esperion Therapeutics, Inc.
$64
SANOFI-AVENTIS U.S. LLC
$55
Novartis Pharmaceuticals Corporation
$48
Ascendis Pharma Inc
$46
Insulet Corporation
$41
Amphastar Pharmaceuticals, Inc.
$35
Neurocrine Biosciences, Inc.
$29
Alexion Pharmaceuticals, Inc.
$26
Tandem Diabetes Care, Inc.
$25
Kyowa Kirin, Inc.
$20
E.R. Squibb & Sons, L.L.C.
$19
Verity Pharmaceuticals Inc.
$17
BETA BIONICS, INC.
$14
Top 3 companies account for 91.2% of 2024 payments
All-time payments by company (2018-2024) ›
Lilly USA, LLC
$430,502
Novo Nordisk Inc
$186,376
Janssen Pharmaceuticals, Inc
$141,141
SANOFI-AVENTIS U.S. LLC
$105,579
AstraZeneca Pharmaceuticals LP
$84,717
Bayer Healthcare Pharmaceuticals Inc.
$38,373
Boehringer Ingelheim Pharmaceuticals, Inc.
$37,087
Merck Sharp & Dohme Corporation
$25,622
Bayer HealthCare Pharmaceuticals Inc.
$19,469
Amarin Pharma Inc.
$16,878
Amgen Inc.
$9,956
AbbVie, Inc.
$8,328
Esperion Therapeutics, Inc.
$4,384
AbbVie Inc.
$2,683
Zealand Pharma US, Inc.
$1,926
Amneal Pharmaceuticals LLC
$1,642
Dexcom, Inc.
$1,465
Becton, Dickinson and Company
$1,155
Abbott Laboratories
$563
ABBVIE INC.
$461
Corcept Therapeutics
$436
Gemini Laboratories, LLC
$407
CeQur Corporation
$355
Novartis Pharmaceuticals Corporation
$212
Embecta Corp.
$203
Insulet Corporation
$200
Merck Sharp & Dohme LLC
$195
Medtronic, Inc.
$190
Tandem Diabetes Care, Inc.
$174
Alexion Pharmaceuticals, Inc.
$172
Medtronic MiniMed, Inc.
$148
Xeris Pharmaceuticals, Inc.
$142
PFIZER INC.
$138
Kowa Pharmaceuticals America, Inc.
$116
Horizon Therapeutics plc
$116
MannKind Corporation
$115
Astellas Pharma US Inc
$101
Ascendis Pharma Inc
$93
Radius Health, Inc.
$72
Shire North American Group Inc
$70
Antares Pharma, Inc.
$67
E.R. Squibb & Sons, L.L.C.
$67
Aytu BioScience, Inc
$65
IBSA Pharma Inc.
$60
Janssen Scientific Affairs, LLC
$57
Takeda Pharmaceuticals U.S.A., Inc.
$54
ARBOR PHARMACEUTICALS, INC.
$54
Mannkind Corporation
$48
Currax Pharmaceuticals LLC
$42
Endo Pharmaceuticals Inc.
$42
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$40
Nevro Corp.
$38
Amphastar Pharmaceuticals, Inc.
$35
GlaxoSmithKline, LLC.
$35
Acerus Pharmaceuticals Corporation
$30
Neurocrine Biosciences, Inc.
$29
Valeritas, Inc.
$23
Eisai Inc.
$22
Ultragenyx Pharmaceutical Inc.
$20
Kyowa Kirin, Inc.
$20
LifeScan, Inc.
$19
RECORDATI_RARE_DISEASES_INC.
$18
VIVUS LLC
$18
Verity Pharmaceuticals Inc.
$17
BETA BIONICS, INC.
$14
Supernus Pharmaceuticals, Inc.
$13
Orexigen Therapeutics, Inc.
$13
VIVUS, Inc.
$8
Top 3 companies account for 67.5% of all-time payments
Associated products mentioned in payments ›
ADVAIR · AFREZZA · AIRSUPRA · Aimovig · Androgel · BAQSIMI · BASAGLAR · BD NANO · BD Nano · BD Nano 2nd Gen Pen Needle · BEVESPI AEROSPHERE · BYDUREON · Belviq · CAMZYOS · CHANTIX · COLOGUARD · CONTRAVE · CREON · CRYSViTA · CeQur Simplicity · Corlanor · Crysvita · DIABETES - DISEASE · Dexcom G6 Transmitter · ELIQUIS · ENTRESTO · EVENITY · Edarbi · Edarbyclor · FARXIGA · FREESTYLE LIBRE · FREESTYLE LIBRE 2 · FREESTYLE LIBRE 3 · FreeStyle Libre · FreeStyle Libre 2 · FreeStyle Libre blood glucose Flash Monitoring System · GVOKE PFS · Guardian Connect · HUMALOG · HUMULIN · HUMULIN R 500 · HUMULIN U · INPEN SMART INSULIN DELIVERY SYSTEM · INVOKANA · JANUVIA · JARDIANCE · Kerendia · Korlym · LANTUS · LEQVIO · LINZESS · LOKELMA · LYRICA · Livalo · MINIMED 780G · MOUNJARO · Minimed 670G System · NASCOBAL · NATPARA · NATPARA (PARATHYROID HORMONE) · NEXLETOL · NEXLIZET · NOCDURNA · Natesto · ONGLYZA · OT Verio Reflect "One Touch Meter and Strips" · Omnia · Omnipod · Ozempic · PRALUENT · PREVNAR 20 · Prolia · QSYMIA · Qsymia · RECORLEV · RETEVMO · RYBELSUS · Repatha · Rybelsus · SIGNIFOR LAR · SOLIQUA · SOLIQUA 100/33 · SOMAVERT · STEGLATRO · STEGLUJAN · STRENSIQ · SYNJARDY · SYNTHROID · Saxenda · Strensiq · Synthroid · TEPEZZA · TLANDO · TOUJEO · TRADJENTA · TRELEGY ELLIPTA · TRULANCE · TRULICITY · Tirosint · Tlando · Tresiba · Trintellix · Tymlos · UBRELVY · UNITHROID · V-GO · VANTA ADAPTIVESTIM · VERQUVO · Vascepa · Veozah · Victoza · Wegovy · XARELTO · XYOSTED · Xultophy 100/3.6 · ZEGALOGUE · ZOMIG · iLet Bionic Pancreas · t-slim insulin pump · t:slim X2 Insulin Pump with Control-IQ · t:slim X2 insulin pump
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
The majority of payments (99%) are for speaking programs and promotional activities, which reflect participation in industry-sponsored educational or marketing events. This is common in endocrinology and does not inherently indicate bias, but patients may wish to be aware. Total industry engagement is in the top 0% for endocrinology in PA.
Geographic Context
Endocrinologists within 10 mi
75
Per 100K population
6.0
County median income
$76,393
Nearest hospital
FORBES HOSPITAL
3.9 mi
3.9 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Bahl is a clinical cardiology specialist, with above-average Medicare volume (top 16% in PA), with speaking/promotional industry engagement in the top 0% of PA peers, with 19 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Bahl experienced with hospital follow-up visit, moderate complexity?
Based on Medicare claims data, Dr. Bahl performed 708 hospital follow-up visit, moderate complexity services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Bahl receive payments from pharmaceutical companies?
Yes. Dr. Bahl received a total of $1,122,929 from 68 companies across 3,225 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Bahl's costs compare to other endocrinologists in Pittsburgh?
Dr. Bahl's average Medicare payment per service is $56. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Bahl) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Specialty guide
Understanding Endocrinology
Common procedures, typical costs, and what industry payments mean in endocrinology.
Same specialty & city
Endocrinologists in Pittsburgh
Browse endocrinologists in Pittsburgh ranked by procedure volume and transparency data.
Highest volume
Top Endocrinologists in PA
Endocrinologists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Endocrinologists in PA
Which PA endocrinologists receive the most from drug and device companies.
By company
Lilly USA, LLC Payments to Doctors
See all physicians who received payments from Lilly USA, LLC.
By company
Novo Nordisk Inc Payments to Doctors
See all physicians who received payments from Novo Nordisk Inc.
By company
Janssen Pharmaceuticals, Inc Payments to Doctors
See all physicians who received payments from Janssen Pharmaceuticals, Inc.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology